KARLA DEAN: Open Payments
NPI 1255928263 · WILMINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 39 payments from 17 companies in 2025. Trend: 2023 $822 · 2024 $1,177 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $67 |
| PFIZER INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Amgen Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $37 |
Products named: REXULTI, MOUNJARO, CAPLYTA, XIFAXAN, JARDIANCE, Omnipod, AIRSUPRA, Exparel.
Industry payments across OH — which companies pay providers there.
